Cargando...
Fabry Cardiomyopathy: Current Treatment and Future Options
Fabry disease is a multisystem X-linked lysosomal storage disorder caused by a mutation in the alpha-galactosidase A gene. Deficiency or reduced activity of alpha-galactosidase A (GLA) is leading to progressive intracellular accumulation of globotriaosylceramide (GL3) in various organs, including th...
Gardado en:
| Publicado en: | J Clin Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8305771/ https://ncbi.nlm.nih.gov/pubmed/34300196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10143026 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|